These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9495859)

  • 21. The effect of serotonergic agents on haloperidol-induced striatal dopamine release in vivo: opposite role of 5-HT(2A) and 5-HT(2C) receptor subtypes and significance of the haloperidol dose used.
    Lucas G; De Deurwaerdère P; Caccia S; Umberto Spampinato
    Neuropharmacology; 2000 Apr; 39(6):1053-63. PubMed ID: 10727716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine.
    Schmidt CJ; Sullivan CK; Fadayel GM
    J Neurochem; 1994 Apr; 62(4):1382-9. PubMed ID: 7907650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between the serotonergic, dopaminergic, and glutamatergic systems in fenfluramine-induced Fos expression in striatal neurons.
    Guerra MJ; Liste I; Labandeira-Garcia JL
    Synapse; 1998 Jan; 28(1):71-82. PubMed ID: 9414020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites.
    De Deurwaerdère P; Bonhomme N; Lucas G; Le Moal M; Spampinato U
    J Neurochem; 1996 Jan; 66(1):210-5. PubMed ID: 8522956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-(m-chlorophenyl)piperazine (mCPP) dissociates in vivo serotonin release from long-term serotonin depletion in rat brain.
    Baumann MH; Ayestas MA; Dersch CM; Rothman RB
    Neuropsychopharmacology; 2001 May; 24(5):492-501. PubMed ID: 11282249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions.
    Gudelsky GA; Nash JF
    J Neurochem; 1996 Jan; 66(1):243-9. PubMed ID: 8522960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
    Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
    Yamamoto BK; Nash JF; Gudelsky GA
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional regulation by dopamine receptors of serotonin release from the rat hippocampus: in vivo microdialysis study.
    Matsumoto M; Yoshioka M; Togashi H; Ikeda T; Saito H
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):621-9. PubMed ID: 8738295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrastriatal taurine increases striatal extracellular dopamine in a tetrodotoxin-sensitive manner in rats.
    Ruotsalainen M; Ahtee L
    Neurosci Lett; 1996 Jul; 212(3):175-8. PubMed ID: 8843101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative action of fenfluramine on the uptake and release of serotonin and dopamine.
    Kannengiesser MH; Hunt PF; Raynaud JP
    Eur J Pharmacol; 1976 Jan; 35(1):35-43. PubMed ID: 1253827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroleptic-like effects of the l-isomer of fenfluramine on striatal dopamine release in freely moving rats.
    Bettini E; Ceci A; Spinelli R; Samanin R
    Biochem Pharmacol; 1987 Jul; 36(14):2387-91. PubMed ID: 2886127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro studies on the mechanism by which (+)-norfenfluramine induces serotonin and dopamine release from the vesicular storage pool.
    Gobbi M; Parazzoli A; Mennini T
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):323-7. PubMed ID: 9774219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary findings with the indirect 5-HT agonist dexfenfluramine on heroin discrimination and self-administration in rats.
    Higgins GA; Wang Y; Sellers EM
    Pharmacol Biochem Behav; 1993 Aug; 45(4):963-6. PubMed ID: 8415837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra.
    Cobb WS; Abercrombie ED
    J Neurochem; 2003 Feb; 84(3):576-84. PubMed ID: 12558977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoflurane anesthesia inhibits clozapine- and risperidone-induced dopamine release and anesthesia-induced changes in dopamine metabolism was modified by fluoxetine in the rat striatum: an in vivo microdialysis study.
    Adachi YU; Yamada S; Satomoto M; Higuchi H; Watanabe K; Kazama T; Mimuro S; Sato S
    Neurochem Int; 2008 Feb; 52(3):384-91. PubMed ID: 17719143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.
    Crespi D; Mennini T; Gobbi M
    Br J Pharmacol; 1997 Aug; 121(8):1735-43. PubMed ID: 9283711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous serotonin modulates histamine release in the rat hypothalamus as measured by in vivo microdialysis.
    Laitinen KS; Tuomisto L; Laitinen JT
    Eur J Pharmacol; 1995 Oct; 285(2):159-64. PubMed ID: 8566134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of quinine on autoreceptor-regulated serotonin release in the rat hippocampus.
    Li MY; Reith ME
    Eur J Pharmacol; 1997 Dec; 340(2-3):145-51. PubMed ID: 9537808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased release of striatal dopamine after long-term treatment with methadone in rats: inhibition by agents which increase central 5-hydroxytryptamine transmission.
    Spampinato U; Nowakowska E; Samanin R
    J Pharm Pharmacol; 1983 Dec; 35(12):831-3. PubMed ID: 6141252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.